British Life Sciences Private Limited - Due diligence report

A 360° intelligence report on British Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2013-12-31 Bangalore South, Karnataka Active Unlisted Active Compliant
Share
Connect MCP
BL British Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

British Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
85/100
Trust Score
Low Risk

British Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 85/100. British Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2013, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 06 Oct 2026 from the latest processed filings. British Life Sciences Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (5.00 cr) · 3 satisfied (8.89 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank3 48.0 cr
Axis Bank Limited1 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2024 - filings overdue.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VENKATASWAMY SRINIVASA REDDY 01234567 Director 01/04/2018 6 yrs Approved
CHITRA REDDY LAKSHMINARAYANA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment88/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 5.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view92/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
28 Jan 2025
Charge satisfied
Canara Bank
12 Dec 2024
Charge created
Axis Bank Limited - 5.00 cr
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
16 Mar 2022
Charge satisfied
Canara Bank
22 Feb 2022
Charge created
Canara Bank - 5.00 cr
20 Mar 2021
Charge satisfied
Canara Bank
08 Feb 2021
Charge created
Canara Bank - 1.90 cr
10 Dec 2019
Charge created
Canara Bank - 1.99 cr
31 Dec 2013
Incorporated
Registered with Roc Bangalore
Director appointed
VENKATASWAMY SRINIVASA REDDY (Director)
Director appointed
CHITRA REDDY LAKSHMINARAYANA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Shri Ram Roller Flour Mills (India) Private Limited U15311UP1999PTC024833 Uttar Pradesh, Uttar Pradesh, India
Shree Proteins Private Limited U15142GJ2011PTC068104 Ahmedabad, Gujarat, India
Vardh Paper Products Private Limited U16000DL2013PTC260224 Delhi, Delhi, India
Unifuds India Private Limited U15549KA2018PTC116180 Bangalore North, Karnataka, India
K.Y Tobacco Works Private Limited U16009DL2017PTC319959 Delhi, Delhi, India
Three Leaves India Pvt Ltd U15491AS1993PTC003972 Gmc, Assam, India
Garodia Agri Foods India Limited U74120UP2011PLC047787 Barabanki, Uttar Pradesh, India
Radhe Agro Industries India Private Limited U15122KA2012PTC062843 Raichur, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify British Life Sciences Private Limited before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of British Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for British Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether British Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for British Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is British Life Sciences Private Limited an active company?

British Life Sciences Private Limited has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is British Life Sciences Private Limited financially healthy?

British Life Sciences Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with British Life Sciences Private Limited?

Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls British Life Sciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does British Life Sciences Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.

Is British Life Sciences Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 68/100 (Moderate).

Is it risky to lend to British Life Sciences Private Limited?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.